Picture [iito] Back into Ad 650x80px
Document › Details

MDxHealth S.A.. (1/28/16). "Press Release: MDxHealth Announces Conference Participation for First Half 2016". Irvine, CA & Herstal.

Organisations Organisation MDxHealth S.A. (Euronext: MDXH.BR)
  Group MDxHealth (Group)
  Organisation 2 KBC Securities N.V.
  Group KBC Group (Group) [since 3/05]
Products Product Knowledge for Growth 2016 Ghent (FlandersBio)
  Product 2 KBC Securities Healthcare Conference 2016 Brussels
Index term Index term MDxHealth–Life Sciences Partners: investor conference, 201603 supply service MDxHealth presents at BioCapital Europe
Persons Person Groen, Jan (Novigenix 201905– CEO before MDxHealth/OncoMethylome CEO before Agendia + Focus Diagnostics)
  Person 2 Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder)

MDxHealth SA (Euronext: MDXH.BR), announced today that it will be participating at the following key conferences during the first half of 2016:

> Bank Degroof Petercam Healthcare CEO Seminar on 03 February, Hotel Bloom Brussels, Belgium

> LSP Biocapital Europe on 09 March, Sofitel Legend Amsterdam, The Grand, The Netherlands

> European Association of Urology Annual Congress, 11-15 March, Messe Munich International, Germany

> KBC Securities Benelux Biotech & Healthcare Conference on 22 March, KBC Securities Brussels, Belgium

> American Urology Association Meeting, 06-10 May, Convention Center of San Diego, California

> FlandersBio Knowledge for Growth on 26 May, ICC Ghent, Belgium

About MDxHealth

MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic and epigenetic (methylation) molecular technologies and assist physicians with the diagnosis of urological cancer, prognosis of recurrence risk, and prediction of response to a specific therapy. For more information, visit and follow us on Twitter at:

For more information:

Dr. Jan Groen, CEO
US: +1 949 812 6979
BE: +32 4 364 20 70

Amber Fennell, Chris Welsh, Hendrik Thys (PR & IR)
Consilium Strategic Communications
UK: +44 20 3709 5701

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of MDxHealth in any jurisdiction. No securities of MDxHealth may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. securities laws.

NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AssureMDx and PredictMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

Record changed: 2017-07-02


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for MDxHealth (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top